New Study Bolsters Cologuard’s Performance in Detecting Colorectal Cancer and Ability to Improve Access to Screening
Go back to New Study Bolsters Cologuard’s Performance in Detecting Colorectal Cancer and Ability to Improve Access to Screening| Exact Sciences Corp (NASDAQ: EXAS) | Delayed: 104.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.91 | 52 Week High | $22.80 | |||
| Open | $104.91 | 52 Week Low | $4.67 | |||
| Day High | $104.91 | P/E | N/A | |||
| Day Low | $104.91 | EPS | $-0.69 | |||
| Volume | 400 | |||||
